Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Olympus ( (JP:7733) ) has shared an update.
Olympus has reported its financial results for FY2025, highlighting a reorganization of its business segments and the divestiture of its orthopedic business. The company recorded a gain from the sale of its Evident operation in FY2024 Q1 and anticipates further changes as it transitions its focus towards gastrointestinal and surgical solutions, impacting its financial reporting and market strategy.
The most recent analyst rating on (JP:7733) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation operates in the medical industry, primarily focusing on endoscopic and therapeutic solutions. The company is reorganizing its business segments to better align with its focus on gastrointestinal and surgical solutions.
Average Trading Volume: 5,021,756
Technical Sentiment Signal: Sell
Current Market Cap: Yen2274.6B
For an in-depth examination of 7733 stock, go to TipRanks’ Stock Analysis page.